Transrectal ultrasound-guided intraprostatic injection of absolute ethanol with and without carmustine: A feasibility study in the canine model

Urology

Volumn 53, Issue 6, 1999, Pages 1245-1251

  Levy, David A ^a   Cromeens, Douglas M ^a   Evans, Robert ^a   Clieton Stephens, L ^a   Von Eschenbach, Andrew C ^a   Pisters, Louis L ^a,b  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; CARMUSTINE; CYTOTOXIC AGENT;

ABSCESS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLADDER; CONTROLLED STUDY; CYTOTOXICITY; DOG; GENERAL ANESTHESIA; INTRATUMORAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROSTATE; PROSTATE CANCER; TISSUE NECROSIS; TRANSRECTAL ULTRASONOGRAPHY;

ANIMALS; ANTINEOPLASTIC AGENTS, ALKYLATING; CARMUSTINE; DOGS; DRUG SCREENING ASSAYS, ANTITUMOR; ETHANOL; FEASIBILITY STUDIES; INJECTIONS; MALE; PROSTATE; RECTUM;

EID: 0033152002     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(99)00043-6     Document Type: Article

References (23)

1. Fujimoto T: The experimental and clinical studies of percutaneous ethanol injection therapy (PEIT) under ultrasonography for small hepatocellular carcinoma. Acta Hepatol Jpn 29: 52-59, 1988.
2. Ellman BA, Parkhill BJ, Curry TS, et al Ablation of renal tumors with absolute ethanol: a new technique. Radiology 141: 619-626, 1981.
3. Yune HY, Klatte EC, Richmond BD, et al. Absolute ethanol in thrombotherapy of bleeding esophageal varices. AJR Am J Roentgenol 138: 1137-1141, 1982.
4. Shiina S, Tagawa K, Unuma T, et al Percutaneous ethanol injection therapy for the treatment of hepatocellular carcinoma. AJR Am J Roentgenol 154: 947-951, 1990.
5. Livraghi T, Festi D, Monti F, et al: US-guided percutaneous alcohol injection of small hepatic and abdominal tumors. Radiology 161: 309-312, 1986.
6. Sironi S, Livraghi T, Angeli E, et al Small hepatocellular carcinoma: MR follow-up of treatment with percutaneous ethanol injection. Radiology 187: 119-123, 1993.
7. Tagawa K, Muto H, Yasuda H, et al: Therapeutic effects of ultrasonically guided ethanol injection for treatment of hepatocellular carcinoma. Jpn J Med Ultrasonics 14: 743-744, 1987.
8. Shiina S, Yasuda H, Muto H, et al Percutaneous ethanol injection in the treatment of liver neoplasms. AJR Am J Roentgenol 149: 949-952, 1987.
9. Lee MJ, Mueller PR, Dawson SL, et al: Percutaneous ethanol injection for the treatment of hepatic tumors: indica-tions, mechanisms of action, technique and efficacy. AJR Am J Roentgenol 164: 215-220, 1995.
10. Iaccarino V, Russo D, Niola R, et al: Total or partial percutaneous renal ablation in the treatment of renovascular hypertension: radiological and clinical aspects. Br J Radiol 62: 593-598, 1989.
11. Pietronigro DD: Antineoplastic solution and method for treating neoplasms. U.S. Patent No. 5,162,115, November 1992.
12. Study Protocol 94-002, Southern Research Institute, Birmingham, Alabama.
13. Ogilvie GK: Chemotherapy, in Withrow SJ, and MacEwen EG (Eds): Small Animal Oncology. Philadelphia, WB Saunders, 1996, pp 70-75.
14. Littrup PJ, William CR, Egglin TK, et al: Determination of prostate volume with transrectal ultrasound for cancer screening. Part II. Accuracy of in vitro and in vivo technique. Radiology 179: 49-53, 1991.
15. Physicians' Desk Reference. Montvall, NJ, Medical Economics Data Production Company, 1997, vol 51, pp 659-660.
16. D'Amico AV, Whittington R, Malkowicz SB, et al: Prostate-specific antigen failure despite pathologically organ-confined and margin negative prostate cancer: the basis for an adjuvant therapy trial. J Clin Oncol 15: 1465-1469, 1997.
17. Partin AW, Lee BR, Carmichael M, et al: Radical prostatectomy for high grade disease: a reevaluation 1994. J Urol 151: 1583-1586, 1994.
18. Ohori M, GoadJR, Wheeler TM, et al: Can radical prostatectomy alter the progression of poorly differentiated prostate cancer? J Urol 152: 1843-1849, 1994.
19. Roach M III, Meehan S, Kroll S, et al: Radiotherapy for high grade clinically localized adenocarcinoma of the prostate. J Urol 156: 1719-1723, 1996.
20. Zagars GK, Pollack A, Kavadi VS, et al: Prostate-specific antigen and radiation therapy for clinically localized prostate cancer. Int J Radiat Oncol Biol Phys 32: 293-306, 1995.
21. Cespedes RD, Pisters LL, von Eschenbach AC, et al: Long-term follow-up of incontinence and obstruction after salvage cryosurgical ablation of the prostate: results in 143 patients. J Urol 157: 237-240, 1997.
22. Pisters LL, von Eschenbach AC, Scott SM, et al: The efficacy and complications of salvage cryotherapy of the prostate. J Urol 157: 921-925, 1997.
23. Summary basis of approval for NDA 17-422 (Carmustine) 1973, Pharmacology Review. Freedom of Information Act.